Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Necrotic, collagen-degraded dentin refers to the outermost layer of a dental carious lesion, often termed infected dentin. This tissue is characterized by a total loss of mineral content and a high concentration of acidogenic bacteria. The organic matrix, primarily type I collagen, is irreversibly denatured by both bacterial proteases and host-derived enzymes like matrix metalloproteinases (MMPs) and cysteine cathepsins (Tjäderhane et al., 2015). Unlike the underlying affected dentin, this necrotic layer lacks the structural integrity to serve as a scaffold for remineralization (Fusayama, 1979). Clinically, it is identified by its soft consistency and lack of sensitivity to stimuli. In restorative dentistry, this layer is typically removed to eliminate the infection and provide a sound substrate for bonding. However, pharmacological interventions such as silver diamine fluoride can be used to arrest the decay process within this layer by killing bacteria and inhibiting degradative enzymes (Horst et al., 2016).
Antimicrobial activity, inhibition of host-derived proteases (MMPs), and collagen cross-linking to stabilize the organic matrix.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Necrotic collagen-degraded dentin.